William L. Hodges
Geen lopende functies
Oorsprong van het eerstegraads netwerk van William L. Hodges
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
29
| Subsidiary | Pharmaceuticals: Major | 29 |
| Public Company | Pharmaceuticals: Major | 5 | |
Pergo, Inc.
 Pergo, Inc. Forest ProductsNon-Energy Minerals Pergo, Inc. is a private company that manufactures and sells laminate and hardwood floors. The company is based in Raleigh, NC.
1
| Private Company | Forest Products | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met William L. Hodges via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Sales & Marketing | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | President | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Sales & Marketing | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Director/Board Member President Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NEUROLOGIX, INC. | Internet Software/Services | President Chief Executive Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Cardinal Capital Management LLC
 Cardinal Capital Management LLC Investment ManagersFinance Founded in 1995, Cardinal Capital Management LLC is a registered investment advisor located in Greenwich, Connecticut. The firm provides advisory services on a discretionary basis to their clients, which include public and private institutions, corporations, public and private pension plans, investment companies, foundations and endowments, mutual funds and high net-worth individuals. Clients invest through separately managed accounts, in one of the mutual funds Cardinal sub-advises, or in one or both of the limited partnerships Cardinal manages. | Investment Managers | Corporate Officer/Principal | |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Treasurer | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Administrative Officer Human Resources Officer Chief Executive Officer Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| IKARIA, INC. | Biotechnology | Treasurer | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
| GSK PLC | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | President Chief Administrative Officer Director/Board Member Chief Executive Officer Director/Board Member Director of Finance/CFO Corporate Officer/Principal Compliance Officer Chief Tech/Sci/R&D Officer | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin Graduate Degree | |
| NEUROBO PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| LIQUIDIA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member Director/Board Member | |
| Glaxo, Inc. | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | ||
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Director/Board Member Founder | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Director/Board Member | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman | |
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Pharmaceuticals: Major | Chief Executive Officer | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Investment Managers | Private Equity Investor | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| Bucknell University | College/University | Undergraduate Degree | |
Tribute Pharmaceuticals, Inc.
 Tribute Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tribute Pharmaceuticals is a specialty pharmaceutical company engaged in the acquisition, licensing and management of pharmaceuticals products in Canada. Tribute is committed to providing patients and physicians with clinically proven pharmaceuticals products that treat recognized medical conditions and diseases. Their goal is to provide quality products that improve patient outcomes. Tribute is seeking to expand its product portfolio in Canada through strategic partnerships with other pharmaceutical, biotechnology and specialty pharmaceutical companies interested in gaining market experience in Canada. | Pharmaceuticals: Major | Founder | |
Vinventions USA LLC
 Vinventions USA LLC Forest ProductsNon-Energy Minerals Vinventions USA LLC manufactures synthetic wine closures. The firm offers co-extruded synthetic wine closures and analyzers for winemakers, wine industry professionals, and consumers. Its closures provide consistent, predictable oxygen management and protect against off-flavors due to oxidation, reduction or cork taint. The company was founded by Gert Noël in 1999 and is headquartered in Zebulon, NC. | Forest Products | Chief Executive Officer | |
| Bayer HealthCare /Diabetes Care Division/ | Medical Distributors | Sales & Marketing | |
| University of Geneva | College/University | Undergraduate Degree | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| THERAPEUTICSMD, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
Nomaco, Inc.
 Nomaco, Inc. Chemicals: SpecialtyProcess Industries Nomaco, Inc. manufactures and distributes of synthetic materials. Its products include fitness rollers; recreational padding, agricultural frost protection and oil containment products; small tubes; and home furnishings. The firm offers flotation, vibration management, and construction solutions. The company was founded by Marc Noël in 1979 and is headquartered in Zebulon, NC. | Chemicals: Specialty | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 38 |
| Verenigd Koninkrijk | 4 |
| Canada | 4 |
| Zweden | 3 |
| Noorwegen | 2 |
Sectoraal
| Health Technology | 31 |
| Commercial Services | 6 |
| Consumer Services | 5 |
| Technology Services | 3 |
| Finance | 3 |
Operationeel
| Director/Board Member | 113 |
| Corporate Officer/Principal | 64 |
| President | 39 |
| Independent Dir/Board Member | 33 |
| Chairman | 27 |
Sterkste connecties
| Insiders | |
|---|---|
| Seth A. Rudnick | 36 |
| Alf Gunnar Martin Nicklasson | 31 |
| Adrian Adams | 19 |
| James Tursi | 16 |
| Neal Fowler | 16 |
| Andrew Koven | 16 |
| Jennifer Lou Armstrong-Owen | 14 |
| Mark Glickman | 14 |
| Elizabeth Cermak | 13 |
| Bruce A. Tomason | 12 |
| A. Sanders | 11 |
| Ted G. Wood | 11 |
| Jacques F. Réjeange | 10 |
| Eric Trachtenberg | 10 |
| Paul J. Rizzo | 10 |
- Beurs
- Insiders
- William L. Hodges
- Bedrijfsconnecties
